A possible role of the cytochrome P450c17α gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: A pilot study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 3, 2004, Pages 234-239

  Amant, Frédéric ^a   Dorfling, Cecilia M ^b   De Brabanter, Jos ^c   Vandewalle, Joos ^c   Vergote, Ignace ^a   Lindeque, B G ^d   Van Rensburg, Elizabeth J ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d STEVE BIKO ACADEMIC HOSPITAL   (South Africa)

Author keywords

CYP17; Ethnic; Leiomyoma; Polymorphism; Race

Indexed keywords

CYTOCHROME P450 17; ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AFRICA; ALLELE; ARTICLE; BLOOD; BODY MASS; CAUCASIAN; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTRACEPTION; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENOTYPE; HUMAN; HYSTERECTOMY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSE; MYOMETRIUM; PARITY; PILOT STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RISK FACTOR; UTERUS MYOMA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYSTERECTOMY; LEIOMYOMA; LOGISTIC MODELS; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, GENETIC; PROBABILITY; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; STEROID 17-ALPHA-HYDROXYLASE; UTERINE NEOPLASMS; VARIATION (GENETICS);

EID: 1542721646     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2004.00422.x     Document Type: Article

References (35)

1. Nakajin S, Shively J, Yuan P-M, Hall P. Microsomal cytochrome P-450 from neonatal pig testis. Two enzymatic activities (17α-hydroxylase and C17,20 lyase) associated with one protein. Biochemistry 1981; 20: 4037-42.
2. Carey A, Waterworth D, Patel K, White D, Little J, Novelli P et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3: 1873-6.
3. Feigelson H, Shames L, Pike M, Coetzee G, Stanczyk F, Henderson B. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998; 58: 585-7.
4. Haiman C, Hankinson S, Spiegelman D, Colditz G, Willett W, Speizer F et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999; 59: 1015-20.
5. Haiman C, Hankinson S, Colditz G, Hunter D, De Vivo I. A polymorphism in CYP17 and endometrial cancer risk. Cancer Res 2001; 61: 3955-60.
6. Picado-Lenard J, Miller W. Cloning and sequencing of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA 1987; 6: 439-48.
7. Kadonaga J, Jones K, Tjian R. Promoter-specific activity of RNA polymerase II transcription by Spl. Trends Biochem Sci 1986; 11: 20-3.
8. Diamanti-Kandarakis E, Bartzis M, Zapanti E, Spina G, Filandra F, Tsianateli T et al. Polymorphism T → r) C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril 1999; 71: 431-5.
9. Thompson J, Rock J. Leiomyomata uteri and myomectomy. In: Rock J, Thompson J, eds. Te Linde's operative gynecology, 8th edn. Philadelphia: Lippincott-Raven, 1997: 732.
10. Balloch E. The relative frequency of fibroid processes in the dark skinned races. Med News 1894; lxiv: 29-35.
11. Witherspoon J, Butler V. The etiology of uterine fibroids. Surg Gynecol Obstet 1934; 58: 57-61.
12. Torpin R, Pund E, Peeples B. The etiologic and pathologic factors in a series of 1741 fibromyomas of the uterus. Am J Obstet Gynecol 1942; 44: 569-74.
13. Marshall L, Spiegelman D, Barbieri R, Goldman M, Manson J, Colditz G et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997; 90: 967-73.
14. Kjerulff K, Guzinsky G, Langenberg P, Stolley P, Adler Moye N, Kazandjian V. Hysterectomy and race. Obstet Gynecol 1993; 82: 757-64.
15. Wilcox L, Koonin L, Pokras R, Strauss L, Xia Z, Peterson H. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994; 83: 549-55.
16. Kjerulff K, Langenberg P, Seidman J, Stolley P, Guzinsky G. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1996; 41: 483-90.
17. Zhu B, Conney A. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998; 19: 1-27.
18. Yager J. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000; 27: 67-73.
19. Shields P, Caporaso N, Falk R, Sugimura H, Trivers G, Trump B et al. Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 1993; 2: 481-5.
20. Taioli E, Trachman J, Chen X, Toniolo P, Garte S. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 1995; 55: 3757-8.
21. Johns M Jr, Paulus-Thomas J. Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal Biochem 1989; 180: 276-8.
22. Dickson R, Stancel G. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 2000; 27: 135-45.
23. Woods M, Barnett J, Spiegelman D, Trail N, Hertzmark E, Longcope C et al. Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst 1996; 88: 1369-74.
24. Shimomura Y, Matsuo H, Samoto T, Maruo T. Up- regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab 1988; 83: 2192-8.
25. Taioli E, Garte S, Trachman J, Garbers S, Sepkovic D, Osborne M et al. Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst 1996; 88: 617.
26. Liehr J, Fang W, Sirbasku D, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986; 24: 353-6.
27. Li J, Li S. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 1987; 46: 1858-63.
28. Swaneck G, Fishman J. Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci USA 1988; 85: 7831-5.
29. Jernström H, Vesprini H, Bradlow L, Narod S. Correspondence. Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst 2001; 93: 554-5.
30. Andersen J, DyReyes V, Barbieri R, Coachman D, Miksicek J. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures. J Soc Gynecol Invest 1995; 2: 542-51.
31. Brandon D, Bethea C, Strawn E, Novy M, Burry K, Harrington M et al. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol 1993; 169: 78-85.
32. Brandon D, Erickson T, Keenan E, Strawn E, Novy M, Burry K et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 1995; 80: 1876-81.
33. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T. Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol 1989; 160: 637-41.
34. Tiltman A. The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 1985; 4: 89-96.
35. Jorde L, Bamshad M, Rogers A. Using mitochondrial and nuclear DNA markers to reconstruct human evolution. BioEssays 1998; 20: 126-36.